Mutagenesis and functional analysis of the varicella-zoster virus portal protein
Journal of Virology · 2024
DOI: 10.1128/jvi.00603-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Melissa A Visalli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA. Hauptthemen laut MEDLINE: Herpesvirus 3, Human, Herpesviridae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Mercer University School of Medicine Masters of Science in Biomedical Sciences.
Abstract (Originalsprache)
Herpesviruses replicate by cleaving concatemeric dsDNA into single genomic units that are packaged through an oligomeric portal present in preformed procapsids. In contrast to what is known about phage portal proteins, details concerning herpesvirus portal structure and function are not as well understood. A panel of 65 Varicella-Zoster virus (VZV) recombinant portal proteins with five amino acid in-frame insertions were generated by random transposon mutagenesis of the VZV portal gene, ORF54. Subsequently, 65 VZV LUC recombinant viruses (TNs) were generated via recombineering. Insertions were mapped to predicted portal domains (clip, wing, stem, wall, crown, and β-hairpin tunnel-loop) and recombinant viruses were characterized for plaque morphology, replication kinetics, pORF54 expression, and classified based on replication in non-complementing (ARPE19) or complementing (ARPE54C50) cell lines. The N- and C-termini were tolerant to insertion mutagenesis, as were certain clip sub-domains. The majority of mutants mapping to the wing, wall, β-hairpin tunnel loop, and stem domains were lethal. Elimination of the predicted ORF54 start codon revealed that the first 40 amino acids of the N-terminus were not required for viral replication. Stop codon insertions in the C-terminus showed that the last 100 amino acids were not required for viral replication. Lastly, a putative protease cleavage site was identified in the C-terminus of pORF54. Cleavage was likely orchestrated by a viral protease; however, processing was not required for DNA encapsidation and viral replication. The panel of recombinants should prove valuable in future studies to dissect mammalian portal structure and function. IMPORTANCE Though nucleoside analogs and a live-attenuated vaccine are currently available to treat some human herpesvirus family members, alternate methods of combating herpesvirus infection could include blocking viral replication at the DNA encapsidation stage. The approval of Letermovir provided proof of concept regarding the use of encapsidation inhibitors to treat herpesvirus infections in the clinic. We propose that small-molecule compounds could be employed to interrupt portal oligomerization, assembly into the capsid vertex, or affect portal function/dynamics. Targeting portal at any of these steps would result in disruption of viral DNA packaging and a decrease or absence of mature infectious herpesvirus particles. The oligomeric portals of herpesviruses are structurally conserved, and therefore, it may be possible to find a single compound capable of targeting portals from one or more of the herpesvirus subfamilies. Drug candidates from such a series would be effective against viruses resistant to the currently available antivirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, Georgia, USA.
ORCID-Profile: Robert J Visalli
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Mercer University School of Medicine Masters of Science in Biomedical Sciences
- Mercer Undergraduate Biomedical Scholar
- Mercer University School of Medicine Summer Scholars Program
Zitieren
APA
Visalli, M. A., Nale Lovett, D. J., Kornfeind, E. M., Herrington, H., Xiao, Y. T., Lee, D., Plair, P., Wilder, S. G., Garza, B. K., Young, A., & Visalli, R. J. (2024). Mutagenesis and functional analysis of the varicella-zoster virus portal protein. Journal of Virology. https://doi.org/10.1128/jvi.00603-23
Vancouver
Visalli MA, Nale Lovett DJ, Kornfeind EM, Herrington H, Xiao YT, Lee D, et al. Mutagenesis and functional analysis of the varicella-zoster virus portal protein. Journal of Virology. 2024. doi:10.1128/jvi.00603-23
BibTeX
@article{Visalli2024,
author = {Visalli, Melissa A and Nale Lovett, Dakota J and Kornfeind, Ellyn M and Herrington, Haley and Xiao, Yi Tian and Lee, Daniel and Plair, Patience and Wilder, S Garrett and Garza, Bret K and Young, Ashton and Visalli, Robert J},
title = {Mutagenesis and functional analysis of the varicella-zoster virus portal protein},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00603-23}
}
EUVIMED